InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Fischel Nathan, Director. Director active across 1 companies, notably Stereotaxis, Inc.. In total, 5 disclosures have been published. The latest transaction was disclosed on 1 July 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
015,527 shares0
Common Stock
SEC:0001493152-22-018358:0·
010,449 shares0
Common Stock
SEC:0001493152-22-000299·
010,449 shares0
Common Stock
SEC:0001493152-22-000299:0·
030,000 shares0
Common Stock
SEC:0001493152-21-016174·
030,000 shares0
Common Stock
SEC:0001493152-21-016174:0·
5 of 5 declarations
About Fischel Nathan
Fischel Nathan is a Director at Stereotaxis, Inc. In this role, he contributes to corporate governance and strategic decision-making. His expertise in the medical sector allows him to provide valuable insights during board discussions, ensuring innovation and performance for the company.
